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Value of the data
This data set will be of value to the scientific community wanting to analyze the binding ability of virus and host cell.
The data show new way to study the biological mechanisms of AAV2 entry. The data may stimulate further research on viral targeted gene delivery.
Data
The data shared in this article is the experimental and theoretical analysis of interaction between cRGD modified AAV2 and host cell (U87).
Experimental design, materials and methods

Cell lines
U87 cells were maintained in an atmosphere containing 5% CO 2 in Dulbecco's modified Eagle's medium (Gibco, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS; PAA, Austria) and 2 mM L-glutamine (Gibco). 
Cell surface binding assays
Cells were resuspended at a density of 2 Â 10 6 cells/mL in binding buffer containing 5% FBS. Equal amounts of viral vectors were incubated with cells at 4°C for 2 h, and unbound vector particles were then removed by washing with PBS. Vector particles bound to HeLa or U87 cells were detected by staining with anti-AAV A20 monoclonal antibodies and subsequent FACS analysis. *P o0.05 versus the corresponding control ( Figs. 1 and 2 ).
